CME Group, Inc. (CME) Reports In-Line Q2 EPS, Sales Miss

CME Group, Inc. (NASDAQ: CME) reported Q2 EPS of $0.79, in-line with the analyst estimate of $0.79. Revenue for the quarter came in at $732 million versus the consensus estimate of $740.64 million.

"Historically low levels of volatility impacted the overall market during the second quarter, although the effect on CME was lessened by the diversity of our product lines," said CME Group Executive Chairman and President Terry Duffy. "Though total volumes were nearly flat year-to- date through the second quarter, our interest rate complex was up 7 percent, a strong outperformance compared with the rest of the market. We continue to see positive economic signs that could potentially lead to a more traditional Federal Reserve monetary policy. This would affect the Fed Funds rate and likely accelerate market activity as firms shift back into growth mode. Already we are nearing historic levels of open interest as we approach 100 million contracts, up 18 percent year-to-date."

For earnings history and earnings-related data on CME Group, Inc. (CME) click here.

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• Pervasip Corp. (PVSP) Reports Q1 EPS of $0.00
• Innodata (INOD) Awarded New Programs from "Magnificent Seven" Big Tech Customer Valued at Approximately $20 Million in Annualized Run Rate Revenue